Impact of Canagliflozin Treatment on Health-Related Quality of Life among People with Type 2 Diabetes Mellitus: A Pooled Analysis of Patient-Reported Outcomes from Randomized Controlled Trials

BACKGROUND: Evidence from patient-reported outcomes in clinical trials may explain health-related behaviors observed in the real world. OBJECTIVE: The purpose of this analysis was to evaluate the effect of treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, compared with place...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jennifer, Delahanty, Linda M., Akapame, Sydney, Slee, April, Traina, Shana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948239/
https://www.ncbi.nlm.nih.gov/pubmed/29313267
http://dx.doi.org/10.1007/s40271-017-0290-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948239/
https://www.ncbi.nlm.nih.gov/pubmed/29313267
http://dx.doi.org/10.1007/s40271-017-0290-4

Ejemplares similares